📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Manufacturing drug co-loaded liposomal formulations targeting breast cancer: Influence of preparative method on liposomes characteristics and in vitro toxicity. (2020)

First Author: Gkionis L

Attributed to: Developing personalized nanotherapies to target placental abnormalities causing fetal growth restriction funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ijpharm.2020.119926

PubMed Identifier: 33010397

Publication URI: http://europepmc.org/abstract/MED/33010397

Type: Journal Article/Review

Volume: 590

Parent Publication: International journal of pharmaceutics

ISSN: 0378-5173